ANTWERP, BELGIUM, Jun 06, 2024 — Scilife and Five Elms Capital are pleased to announce a strategic growth investment aimed at accelerating Scilife’s mission to transform quality management in the life sciences sector. This investment by Five Elms Capital, a leading global growth equity firm, marks a significant endorsement of Scilife’s vision. Their partnership will allow Scilife to bolster the market presence and adoption of Scilife’s innovative electronic Quality Management System (QMS).
"We're excited to work with the like-minded team at Five Elms—a partner who is as committed as we are in making Smart Quality an instrumental catalyst for value creation. This approach ensures that every team member not only understands their role in upholding quality but is also equipped to contribute effectively."
Filip Heitbrink, CEO at Scilife
Quality management is crucial in every industry, particularly within the life sciences sector, where the stakes are significantly high. However, fostering organizational-wide adherence to quality initiatives presents considerable challenges. Frequently, teams outside the quality department lack a clear understanding of what quality entails and how it benefits their respective roles.
Scilife aims to resolve this industry problem. By combining continuous learning, motivational elements like gamification, and advanced data analytics to create a comprehensive smart QMS, Scilife promotes organization-wide commitment to quality.
This integration ensures that quality management encompasses not only the maintenance of regulatory standards but also continuous improvement and engagement throughout the organization.
"Quality is not just a compliance requirement; it's a strategic asset that can significantly differentiate life sciences companies in the market. Our investment in Scilife underscores our belief in their vision to embed quality into the DNA of every organization. We are excited to support Scilife in its next phase of growth and innovation."
Joe Onofrio, Partner at Five Elms Capital
About Scilife
Founded in 2017, Scilife is a leading quality management solution, providing comprehensive tools to transform quality into a competitive advantage for life sciences. Scilife's Smart Quality framework enables organizations to seamlessly manage their complex workflows, reducing the burden on quality teams and allowing them to focus on driving value.
Trusted by global quality-focused organizations, including Novartis, Biocartis, Yusen Logistics, Polpharma, and Pendulum, Scilife is committed to improving efficiency, simplifying regulatory compliance, and making quality an engaging culture for everyone on board. The impact? Improving patients’ lives.
About Five Elms Capital
Five Elms Capital is a global growth equity firm that invests in fast-growing B2B software businesses that users love. Five Elms provides capital and resources to help companies accelerate growth and further cement their role as industry leaders.
Since the firm’s inception in 2007, Five Elms has focused exclusively on software investing, building an unmatched network and deep domain expertise. Today, with over $2.4 billion in assets under management and a global team of over 70 investment professionals, Five Elms has invested in more than 65 software platforms globally.
For more information about Five Elms Capital, visit fiveelms.com
